[HTML][HTML] Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
R Sharan, SR Ganatra, AN Bucsan… - The Journal of …, 2022 - Am Soc Clin Investig
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
R Sharan, SR Ganatra, AN Bucsan… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective CD4+ T cell-independent …
immunodeficiency virus coinfection have revealed protective CD4+ T cell-independent …
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
R Sharan, AN Bucsan, SA Khader - 2022 - digitalcommons.wustl.edu
The tuberculosis and HIV copandemic continues to pose a major healthcare burden in
resource-limited countries (1). HIV coinfection predisposes the host to reactivation of latent …
resource-limited countries (1). HIV coinfection predisposes the host to reactivation of latent …
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model.
R Sharan, SR Ganatra, AN Bucsan, J Cole… - Journal of Clinical …, 2022 - go.gale.com
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective [CD4. sup.+] T cell …
immunodeficiency virus coinfection have revealed protective [CD4. sup.+] T cell …
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
R Sharan, SR Ganatra, AN Bucsan… - Journal of Clinical …, 2022 - search.proquest.com
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective CD4+ T cell-independent …
immunodeficiency virus coinfection have revealed protective CD4+ T cell-independent …
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model.
R Sharan, SR Ganatra, AN Bucsan, J Cole… - The Journal of …, 2022 - europepmc.org
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
[HTML][HTML] Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
R Sharan, SR Ganatra, AN Bucsan, J Cole… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
R Sharan, SR Ganatra, AN Bucsan, J Cole… - Journal of Clinical …, 2022 - profiles.wustl.edu
Studies using the nonhuman primate model of Mycobacterium tuberculosis/simian
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …
immunodeficiency virus coinfection have revealed protective CD4+ T cell–independent …